Navigation Links
VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
Date:4/3/2009

SAN FRANCISCO, April 3 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that it has received a letter, dated March 31, 2009, from the staff of the NASDAQ Stock Market informing the Company that it does not currently comply with NASDAQ Marketplace Rule 4310(c)(3). NASDAQ Marketplace Rule 4310(c)(3) requires companies maintain either: (i) $2,500,000 in stockholders' equity; (ii) a market value of listed securities of $35,000,000; or (iii) net income from continuing operations of $500,000 in the most recently completed fiscal year or two of the last three most recently completed fiscal years. The Company intends to submit a specific plan to achieve and sustain compliance with the $2,500,000 stockholders' equity standard by April 15, 2009, including the time frame for completion of the compliance plan. If the NASDAQ staff determines that the Company's plan does not adequately address the issue noted above, the NASDAQ staff will provide written notice that the Company's securities will be delisted. At that time, the Company may appeal the NASDAQ staff's determination to a NASDAQ Listing Qualifications Panel (the "Panel"), which would stay any further delisting action by NASDAQ pending a final decision by the Panel. No assurances can be provided that NASDAQ will grant the Company sufficient time to execute its plan to insure that it will maintain its NASDAQ listing.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease. VIA's lead candidate, VIA-2291, targets a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
2. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
3. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
4. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
5. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
6. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
7. VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
8. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
9. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
10. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
11. VIA Pharmaceuticals Complies With NASDAQ Rules

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/...a leading provider of tools and services for drug ...uced Living Image 4.0 software for IVIS® in v...the more than 800 Caliper IVIS systems currently i....0 features advanced spectral unmixing tools to en...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Neurostimul.../www.reportlinker.com/p0164232/Neurostimulation---... neurostimulation market stands enthused by the gr...rise in age-related diseases such as, Parkinson,s,...
(Date:12/2/2009)..., COPENHAGEN, Dec. 2 The world,s f...oprene technology, a breakthrough alternative to r...e manufacture of synthetic rubber with renewable b...his week. One tire will be on display at a lounge ...ernational Airport throughout December 21, while t...
(Date:12/2/2009)..., LELYSTAD, The Netherlands, December 2 /PRNew...d biotechnology company focusing on protein mimick...eutics today announced that it,has appointed Wim E..., Dr. Mol will be responsible for all of Pep...nt and strategic direction of the company. He brin...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2
...tricity-usage growth rate, we wont have enough pow...l educational software company. With a 2.5 percent... will not have enough energy to keep the lights on...ah Still, founder of Blue Spark, LLC. , ,Paul Wils...cs at the University of Wisconsin-Madison, seconde...
... into ballgame, too , ,As the manufacturing secto...tmare, recent or soon-to-be college grads may view...hey could only see what really goes on in todays f...ric control systems, robotic welding, remote senso... sector simply wouldnt be possible without the com...
...sire to align best business practices to state gov...e senator refer to the Sarbanes-Oxley Act of 2002 ...ts look at this concept a little closer. President...he wake of corporate accounting scandals, most not... raise standards of corporate accountability and p...
Other Biology Technology:Software Company Tackles Energy Shortage Issues 2Manufacturing still viable career 2Manufacturing still viable career 3My View - State Government Needs Integrity To Build Investor Confidence 2
(Date:12/2/2009)...A Children exposed to secondhand cigarette smoke ...n adulthood, even if they never smoked. , Resul...logy, Biomarkers & Prevention , a journal of the A...f a special tobacco focus in the December issue. ...ill be diagnosed with lung cancer; more than 159,0...
(Date:12/2/2009)...A Mexican-American adolescents exposed to cigaret...k up the habit themselves, and this may be part of... initiation, according to new study findings. , ... United States and highlights the global implement...onvention on Tobacco Control, which includes guide...
(Date:12/2/2009)... from the University of Georgia College of Veterin...ery that could open new avenues for treating Ichth...ingle-celled protozoan parasite that commonly atta...ome sequencing, researchers found that Ich harbors... Bacteroides, which are usually found free-living,...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Want to attract the opposite sex 3F Its in the Smile 51639 1Want to attract the opposite sex 3F Its in the Smile 51639 2Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 1Encompass Group to Offer the Liftaem 28TM 29 Lateral Patient Transfer System 51635 2WellNet Introduces Facebook like Point to Point Healthcare 51632 1WellNet Introduces Facebook like Point to Point Healthcare 51632 2WellNet Introduces Facebook like Point to Point Healthcare 51632 3WellNet Introduces Facebook like Point to Point Healthcare 51632 4
...am Institute study has found that a protein known ...ant function, that of initiating DNA repair. The s...ar Cell, points to new targets for treatment of ca...tute,s Signal Transduction Program, and his collea...scription Factor-2") is activated by a protein kin...
...landowners can greatly increase the survival rate ...ey plant, according to research conducted here. ,...ver the last decade or so," said Dr. Eric Taylor, ..., "Some landowners have had to replant two, three ...ng survival." , Second-year data from an ongoing c...
...center comparison of equipment that can analyze th...te a genetic "fingerprint," suggests these differe...e thought. , Published in the May 2005 issue of N...e mounds of information generated by these systems...fferent systems are used by many different laborat...
Other Biology News:New understanding of DNA repair may pave way to cancer treatments 2Shift of weather patterns necessitates rethinking of reforestation methods 2Shift of weather patterns necessitates rethinking of reforestation methods 3Different microarray systems more alike than previously thought 2Different microarray systems more alike than previously thought 3
...s a cytochrome P450 (CYP450) metabolite postulated...l vasculature. In rat cerebral microvessels, 20-HE...uced autoregulatory vasoconstriction. 20-HETE is e...oncentration of free 20-HETE (20-40 pg/ml in human...
... Mutagenesis System enables you to insert a transp...et DNA by in vitro transposition. It uses TnsABC* ...domly into the DNA target. Target DNA may be a pla...epending on your interests (6-8). If the insertion...
...erminal kinase (JNK) is one of the several main MA...s a sensitive reporter for studying gene regulatio...crease in sensitivity in comparison to the standar...irefly luciferase catalyzes the oxidative carboxyl...
...afe™ PCR System is the only PCR system that e...me. It provides accuracy, consistency, and dependa...operty of the DNA templates. This system uses EPIC...end of thermostable enzymes that is capable of amp...
Biology Products: